Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SANT study: phenoxymethylpenicillin vs no antibiotics in GAS-negative acute tonsillitis
2023-508542-18-00Phase 4Authorised
- Sponsor
- Region Jönköpings Län
- Start
- Nov 2023
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of phenoxymethylpenicillin in acute tonsillitis (2 arms), sponsored by Region Jönköpings Län. Primary endpoint: Time to resolution of all symptoms. Planned start Nov 2023; status: authorised.
02
Drugs
phenoxymethylpenicillin
03
Conditions
acute tonsillitis
Beyond the preview
Go deeper on 2023-508542-18-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-508542-18-00.